| Type 2 Diabetes Mellitus |
1 |
1 |
| Retinopathy |
0 |
0.98 |
| SGLT2 Inhibitor |
0 |
0.99 |
| Retinal Diseases |
0 |
0.61 |
| Diabetic Retinopathy |
0 |
0.97 |
| Diabetic Microvascular Complications |
0 |
0.46 |
| Sulfonylureas |
0 |
0.29 |
| DPP-4 Inhibitors |
0 |
0.23 |
| Clinical Research |
0 |
0.12 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Diabetic Nephropathy |
0 |
0.08 |
| Alcohol Use |
0 |
0.06 |
| Cerebrovascular Accident |
0 |
0.06 |
| Exercise |
0 |
0.06 |
| Renal Disease |
0 |
0.06 |
| Vascular Endothelial Growth Factor |
0 |
0.06 |